PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma.


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
12 Feb 2021
Historique:
received: 02 12 2020
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 23 2 2021
Statut: epublish

Résumé

We have previously demonstrated potent antitumor effects of PARP targeted alpha-therapy with astatine-211-MM4 ([

Identifiants

pubmed: 33615184
doi: 10.1021/acsptsci.0c00206
pmc: PMC7887847
doi:

Types de publication

Journal Article

Langues

eng

Pagination

344-351

Subventions

Organisme : NCI NIH HHS
ID : R01 CA219006
Pays : United States

Informations de copyright

© 2021 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): R.H.M., D.A.P., and M.M. are inventor and co-inventors on a pending patent for a 211At-PARP targeted radiotherapy. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Clin Oncol. 2020 Dec;17(12):725-741
pubmed: 32760014
Oncoimmunology. 2018 Jan 16;7(4):e1412909
pubmed: 29632728
Org Lett. 2018 Apr 6;20(7):1752-1755
pubmed: 29561158
Nature. 2017 Aug 31;548(7669):537-542
pubmed: 28783722
Nat Commun. 2020 Feb 18;11(1):931
pubmed: 32071302
Lancet Oncol. 2020 Sep;21(9):1155-1164
pubmed: 32771088
J Nucl Med. 2010 Feb;51(2):311-28
pubmed: 20080889
Nat Commun. 2020 Mar 20;11(1):1508
pubmed: 32198351
Mutat Res. 2014 Jul;765:48-56
pubmed: 24769180
J Nucl Med. 2020 Jun;61(6):850-856
pubmed: 31676730
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
Clin Cancer Res. 2019 Jun 15;25(12):3643-3657
pubmed: 30824583
Nat Commun. 2017 Feb 21;8:14572
pubmed: 28220772
Mol Cancer Ther. 2019 Jul;18(7):1195-1204
pubmed: 31072830
Radiat Res. 1980 May;82(2):277-89
pubmed: 6246560
J Transl Med. 2014 Apr 29;12:107
pubmed: 24779345
Int J Radiat Biol. 2011 Apr;87(4):372-84
pubmed: 21171940

Auteurs

Hannah Dabagian (H)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Tahereh Taghvaee (T)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Paul Martorano (P)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Daniel Martinez (D)

Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.

Minu Samanta (M)

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United States.
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

Carolyn M Watkins (CM)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Richard Chai (R)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Adam Mansfield (A)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Thomas J Graham (TJ)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

John M Maris (JM)

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United States.

Daniel A Pryma (DA)

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United States.
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

Robert H Mach (RH)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Mehran Makvandi (M)

Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

Classifications MeSH